These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19644022)

  • 1. Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology.
    Hanlon K; Harries LW; Ellard S; Rudin CE
    J Mol Diagn; 2009 Sep; 11(5):450-7. PubMed ID: 19644022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 13q14 status in patients with chronic lymphocytic leukemia using single nucleotide polymorphism-based techniques.
    Hanlon K; Ellard S; Rudin CE; Thorne S; Davies T; Harries LW
    J Mol Diagn; 2009 Jul; 11(4):298-305. PubMed ID: 19460942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic study.
    Nomdedéu JF; Lasa A; Ubeda J; Saglio G; Bellido M; Casas S; Carnicer MJ; Aventín A; Sureda A; Sierra J; Baiget M
    Haematologica; 2002 Aug; 87(8):828-35. PubMed ID: 12161359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.
    Fonseca R; Oken MM; Harrington D; Bailey RJ; Van Wier SA; Henderson KJ; Kay NE; Van Ness B; Greipp PR; Dewald GW
    Leukemia; 2001 Jun; 15(6):981-6. PubMed ID: 11417487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis for loss of heterozygosity on chromosome arm 13q by STR analysis or SNP sequencing can replace analysis of FLT3-ITD to detect patients with prognostically adverse AML.
    Schnittger S; Haferlach C; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2014 Dec; 53(12):1008-17. PubMed ID: 25183446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.
    Ahmed M; Giles F; Joe Y; Weber DM; Jilani I; Manshouri T; Giralt S; De Lima M; Keating M; Albitar M
    Eur J Haematol; 2003 Sep; 71(3):174-8. PubMed ID: 12930317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent patterns of allelic loss in natural killer cell lymphoma.
    Siu LL; Chan V; Chan JK; Wong KF; Liang R; Kwong YL
    Am J Pathol; 2000 Dec; 157(6):1803-9. PubMed ID: 11106552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.
    Walker BA; Leone PE; Chiecchio L; Dickens NJ; Jenner MW; Boyd KD; Johnson DC; Gonzalez D; Dagrada GP; Protheroe RK; Konn ZJ; Stockley DM; Gregory WM; Davies FE; Ross FM; Morgan GJ
    Blood; 2010 Oct; 116(15):e56-65. PubMed ID: 20616218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer.
    Dong JT; Boyd JC; Frierson HF
    Prostate; 2001 Nov; 49(3):166-71. PubMed ID: 11746261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
    Lin YW; Sheu JC; Liu LY; Chen CH; Lee HS; Huang GT; Wang JT; Lee PH; Lu FJ
    Eur J Cancer; 1999 Nov; 35(12):1730-4. PubMed ID: 10674021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
    Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
    Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of the minimal region of loss at 13q14 in multiple myeloma.
    Elnenaei MO; Hamoudi RA; Swansbury J; Gruszka-Westwood AM; Brito-Babapulle V; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):99-106. PubMed ID: 12461754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.
    Zojer N; Königsberg R; Ackermann J; Fritz E; Dallinger S; Krömer E; Kaufmann H; Riedl L; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
    Blood; 2000 Mar; 95(6):1925-30. PubMed ID: 10706856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of single nucleotide polymorphism-based mapping arrays to detect copy number changes and loss of heterozygosity in multiple myeloma.
    Walker BA; Morgan GJ
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):186-91. PubMed ID: 17229333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.